abstract |
The present invention provides a replication competent hepatitis C virus that includes a heterologous polynucleotide present in the 3′ non-translated RNA. The invention also includes methods for modifying a hepatitis C virus, selecting a replication competent hepatitis C virus, detecting a replication competent hepatitis C virus, and identifying a compound that inhibits replication of a hepatitis C virus. |